Earlier this week TMRW Life Sciences (TMRW) announced that it has launched the world’s first automated cryo specimen management solution for embryos and eggs used in in vitro fertilization (IVF). TMRW’s proprietary platform has been installed in multiple premier fertility clinics in the U.S., launching the modern era of integrated, software-enabled management of the millions of eggs and embryos central to modern IVF. The TMRW…
The knock-on effects of the pandemic that disrupted our lives in 2020 are still prevalent, despite the hopeful wishes of a “Happy New Year”. These disruptions, in particular, have affected those looking to plan a family. With many wedding plans postponed, dating lives interrupted or halted altogether, family plans have also been affected. Studies have shown that 6 in 10 women are anxious…
Women’s reproductive healthcare in Asia gets a boost with the launch of Yesmom’s at-home blood-testing kit for female fertility in Thailand, designed to help women stay on the front foot of their reproductive health from the comfort of home. Building on four years of expertise in women’s health, Yesmom is working on becoming the go-to brand in Thailand in the ‘proactive health’ category. With…
Kiran Roest is no stranger to healthcare innovation. Following a first-class BA in Natural Sciences from Cambridge University and a PhD in Immunology & Virology from Imperial College London, Kiran has added 15+ years of experience driving innovation initiatives at world-leading Life Science and Medtech organisations, including Thomson Reuters and Pfizer, across clinical and scientific research, business development and consulting. She has…
Digital health and virtual care technologies have proved invaluable during the COVID-19 pandemic in keeping patients and their care teams in virtual contact, accelerating digital transformation in healthcare. Digital technologies including remote patient monitoring, cloud-based services and AI are playing an ever more important part in achieving better patient outcomes, better patient and staff experiences, and low cost of care – the…
Eli, a company enabling women to own their fertility and health decisions with a novel hormone tracking technology, today announced its $1.5 million USD seed round led by Vectr Ventures & 2048 Ventures. The round closed in December 2020 with the participation of Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and serial entrepreneur Steven Arless, who also joined the board. The…
In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share Posy’s founding story as told by Co-founder Caitlin Nelson. Posy‘s mission is to…
Fertifa, named after its mission of providing “Fertility For All”, has secured £1 million in financing from venture capital firm, Passion Capital, and strategic angel investors. The new round of funding will accelerate Fertifa’s growth in the UK and Europe while enhancing the company’s tech-enabled platform – a digital portal for patients to access innovative, telehealth solutions designed to offer holistic, patient-centric…
